Success Stories: In Just 13 Days, EB1-A Approval Won for an Indian Postdoctoral Research Associate in Cardiovascular Disease with Over 1,000 Citations, Thanks to Premium Processing and Our Teamwork
Client’s Testimonial:
“Thank you again for your help.”
On November 1st, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Cardiovascular Disease (Approval Notice).
General Field: Cardiovascular Disease
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: India
State of Residence at the Time of Filing: Virginia
Approval Notice Date: November 1st, 2022
Processing Time: 13 days (Premium Processing Requested)
Case Summary:
An EB1-A (Alien of Extraordinary Ability) client from India won approval in just 13 days, thanks to our diligent teamwork on his case preparation and the premium processing upgrade that he opted for. Since the EB1-A is a kind of employment-based immigrant visa designed for foreign individuals who are specialized in a certain chosen area of work, our team made sure that his case was built on the merits of his achievements thus far. Some of the data our team collected for this petition are as follows:
- He is one of the few leading experts in cardiovascular diseases, and he has achieved a consistent and notable record of success and influence in this area of study. He is especially well-known for the development of mitochondria-targeted drug delivery for atherosclerosis, the pathogenesis of atherosclerotic lesions, and the use of metformin for treating atherosclerosis.
- He has conducted at least 25 reviews for journals that include international scientific journals of repute.
- His work has also resulted in 25 peer-reviewed scientific articles. It is clear not only that he is conducting important original research, but that his work is considered majorly significant by the editors of the top journals in the field.
- Due to its great applicability in the field, his research in cardiovascular diseases has been cited a massive total of 1,134 times in 56 countries all over the world according to Google Scholar.
- His research on metformin as an anti-aging drug and its implementation in his peers’ studies positions his work as a major contribution to the field of cardiovascular diseases. Furthermore, his study has received funding from the Government of India’s Ministry of Science & Technology.
- And we also gathered letters of recommendation from over 4 experts who had followed his work over the years. One of them said:
It was these details that helped make the case a convincing one winning the approval quickly. We are proud to have worked with him and we wish him the best of luck in his future endeavors.